Further, systemic treatment with a DNA Methyltransferase (DNMT) inhibitor in mice carrying FXS‐induced pluripotent stem cell (iPSC)‐derived transplants robustly induced FMR1 expression in the affected tissue, which was maintained for a prolonged period. Here, FMR1 is linked to fragile X syndrome.